Hepatocytes Fuel Pancreatic Cancer Liver Metastasis Via Serine

Hepatocytes, the primary functional cells of the liver, have been identified as key enablers of pancreatic cancer's spread to the liver, according to research published online in Nature on September 23, 2026. The study, identified by the digital object identifier 10.1038/s41586-026-11051-z, details a mechanism by which metastatic pancreatic ductal adenocarcinoma (PDAC) hijacks liver cells to support its own growth and survival.

Specifically, the research found that PDAC tumors in the liver that are deficient in their ability to synthesize the amino acid serine can induce hepatocytes to produce it. This reprogramming of liver cells provides a critical nutrient source for the cancer cells, thereby promoting tumor growth and enhancing their ability to survive within the liver microenvironment. Serine is a non-essential amino acid that plays a vital role in various cellular processes, including protein synthesis, nucleotide biosynthesis, and the production of other important molecules like glycine and cysteine. Its availability is crucial for rapidly dividing cells, such as cancer cells, making its de novo synthesis by host cells a significant advantage for tumor progression.

The findings suggest a complex interplay between the tumor and its metastatic site, where the cancer actively manipulates the host's cellular machinery to its benefit. This discovery opens new avenues for understanding the metastatic cascade of pancreatic cancer and could potentially lead to novel therapeutic strategies. By targeting the metabolic pathways that allow tumors to exploit hepatocytes for serine production, researchers may be able to disrupt the tumor's ability to establish and grow in the liver.

Pancreatic cancer remains one of the deadliest forms of cancer, characterized by late diagnosis and aggressive metastasis, particularly to the liver. The liver is the most common site for PDAC metastasis, and the presence of liver metastases is a major determinant of patient prognosis. Understanding the specific molecular mechanisms that facilitate this spread is therefore of paramount importance for developing more effective treatments. This study contributes significantly to that understanding by elucidating a previously unrecognized role for hepatocytes in supporting PDAC liver metastasis through serine provision. The research was published in the journal Nature, a leading international weekly journal of science.